Nachrichten zur Eli Lilly & Co. Aktie

Is Eli Lilly an Undervalued Growth Stock to Buy Now?

Eli Lilly (NYSE: LLY) is generating billions in cash flow growth due to product innovation. Start Your Mornings Smarter! Wake up…

1 Spectacular Growth Stock That Could Join Nvidia, Tesla, Apple, and Others in the $1 Trillion Club

This growth stock is expected to experience a surge in revenue, profit, and cash flow in the upcoming years. Start Your…

8 Giant Stock Champs In 2024 Predicted To Win Again In 2025

Missed out on giant S&P 500 winners this year like Nvidia and Eli Lilly? Dont worry: Analysts think youll get…

Why "Hims and Hers" Stock Plummeted

The Short discusses a 15% drop in Hims & Hers stock following an FDA announcement ending the shortage of Eli…

Wall Street ends higher on gains by most megacaps

STORY: Wall Streets main indexes closed higher on Monday thanks to gains in many of the Magnificent Seven tech stocks.The…

Eli Lilly, Novo Nordisk Stocks Rise. Only One Is Operating From a Position of Strength.

…

Better Buy: Eli Lilly or Novo Nordisk?

Novo Nordisk stock crashed 17% on Friday after revealing disappointing trial results.…

Eli Lilly, Novo Nordisk Stocks Rise. One of These Obesity Drugmakers Just Hit a Landmark.

…

Stocks to Watch Monday: Honda, Nissan, Novo Nordisk, Eli Lilly

…

These Stocks Are Moving the Most Today: Honda, Nissan, Qualcomm, Eli Lilly, Tesla, Rumble, and More

…

Does This News From the FDA Make Eli Lilly a Buy for 2025?

Eli Lilly (NYSE: LLY) soared more than 60% from the start of the year through its peak this summer, thanks…

Is Merck the Next Big Weight-Loss Stock?

Watch out, Eli Lilly and Novo Nordisk. Merck (NYSE: MRK) is hungrily looking to take a bite out of the…

3 Stocks That Could Join the Trillion-Dollar Market Cap Club Next Year

Believe it or not, there are now nine publicly traded U.S. companies worth $1 trillion or more.Where to invest $1,000…

Novo Nordisk raises expectations for Eli Lilly after CagriSema slipup

…

2 Dividend-Growth Stocks That Billionaire Izzy Englander Loves

Investing in dividend stocks is a great strategy for many reasons, including the potential they offer you to significantly boost…

Is Now a Good Time to Buy the Dip in Eli Lilly Stock?

Since Eli Lilly reported third-quarter earnings on Oct. 30, its shares have had a prolonged sell-off.…

Is Now a Good Time to Buy the Dip in Eli Lilly Stock?

…

FDA approves Eli Lillys weight loss drug Zepbound for sleep apnea, expanding use in U.S.

The agencys decision expands the use of Zepbound and could potentially pave the way for Eli Lilly to gain broader…

Healthcare Equity Strategist on Novo Setback

As Novo Nordisk experimental drug falls short of target, Mizuho Securities Healthcare Equity Strategist Jared Holz says Eli Lilly will…

Nvidia, Eli Lilly lead Fridays market cap stock movers By Investing.com

Nvidia, Eli Lilly lead Fridays market cap stock movers…

Eli Lilly: Improved Competitive Position In Obesity Market, But Strong Execution Is A Must Now

…

Why Novo Nordisk Stock Got Destroyed Today, but Eli Lilly and Viking Stocks Are Up

Todays sell-off in Novo Nordisk may be the buying opportunity youve been waiting for.…

Eli Lilly, Avago lead market cap stock movers this Friday By Investing.com

Eli Lilly, Avago lead market cap stock movers this Friday…

FedEx, Eli Lilly, Occidental rise premarket; Nike, Novo Nordisk fall By Investing.com

FedEx, Eli Lilly, Occidental rise premarket; Nike, Novo Nordisk fall…

Focus: In weight loss battle, Novo and Lilly face growing offensive from licenced copies

As Novo Nordisk and Eli Lilly expand sales of their popular diabetes and weight-loss drugs, cheaper copies of their patented…

LLY Stock Up as FDA Removes Mounjaro, Zepbound From Shortage List

Eli Lilly stock gains as the FDA removes tirzepatide drugs from the drug shortage list following a thorough reevaluation.…

Eli Lily GLP-1 shortage ends, FDA says: Hims & Hers stock falls

Hims & Hers Health (HIMS) shares tumble after the US Food and Drug Administration (FDA) announced that the shortage in…

Eli Lilly dips despite FDA confirming shortage of GLP-1 tirzepatide is over By Investing.com

Eli Lilly dips despite FDA confirming shortage of GLP-1 tirzepatide is over…

Eli Lilly: FDA erklärt Engpass bei Tirzepatid für beendet – Rückenwind für Mounjaro und Zepbound

Eli Lilly sichert sich durch Innovation und starke Produkte wie Mounjaro und Zepbound einen führenden Marktanteil im boomenden Gewichtsabnahmesektor…

IBD 50s Hims & Hers Tumbles After FDA Pulls Lillys Weight-Loss Drug From Shortage List

Hims stock skidded Thursday after the FDA determined Eli Lillys tirzepatide — which sells as a weight-loss drug — is…

FDA says Eli Lillys weight loss drug Zepbound is no longer in shortage

The decision that will eventually bar compounding pharmacies from making unbranded versions of the injection.…

Hims & Hers Health falls as FDA issues unfavorable compounded GLP-1 decision

Hims & Hers Health (NYSE:HIMS) is down 7% in early morning trading after the U.S. FDA determined that there is…

Zealand Pharma And Eli Lilly: Strategic Focus On Weight Management And Future Outlook

…

These 2 Stocks Just Declared Dividend Raises That Kick In Next Year. Should You Buy?

It isnt easy to find steady and reliable dividend payers in the pharmaceutical industry. The key reason is simple: Drug…

This Is Huge News for Eli Lilly Investors @themotleyfool #stocks $LLY $NVO $HIMS

Eli Lilly just gave investors several reasons to cheer.…

This Is Huge News for Eli Lilly Investors

Eli Lilly just gave investors several reasons to cheer.…

Ozempic Dethroned? A Head-to-Head Study Confirms This Company Has the Best Weight Loss Drug

When you think of a top weight loss drug, chances are that Ozempic is the name that first comes to…

Eli Lilly Is Putting Dividend Growth Stocks to Shame With Yet Another Huge Increase to Its Payout

Dividend investors often prioritize stocks that have long track records for raising their payouts. But that can be a mistake.…

Eli Lillys Alzheimers treatment approved in China

Chinas medical regulator has approved Eli Lillys treatment for early Alzheimers, providing patients with another option after Eisai and Biogens…

Eli Lillys Alzheimers treatment approved in China By Reuters

Eli Lillys Alzheimers treatment approved in China…

Eli Lilly Alzheimer’s drug donanemab approved in China By Investing.com

Eli Lilly Alzheimer’s drug donanemab approved in China…

Eli Lilly: A Rare Buying Opportunity

…

4 Big Drug Stocks That May Continue to Outperform in 2025

Gilead, Eli Lilly, Vertex Pharmaceuticals and AbbVie have outperformed the industry this year and are likely to see continued momentum…

Prediction: These Could Be the Best-Performing Pharma and Biotech Stocks Through 2030

Pharmaceutical and biotech stocks often are seen as steady and safe options for investors for one particular reason. Patients need…

2 Brand-New Reasons to Buy Eli Lilly Stock Right Now, and 2 Reasons to Be Cautious

As a major pharmaceutical company that is constantly innovating and developing new treatments, Eli Lilly (NYSE: LLY) is always providing…

Did Eli Lilly Just Say "Checkmate" to Novo Nordisk?

Eli Lilly (NYSE: LLY) and Novo Nordisk (NYSE: NVO) have competed for decades. Theyre both leaders in the areas of…

2 Weight Loss Stocks That Are Screaming Buys in December

With drugs like Novo Nordisks Wegovy becoming household names over the last couple of years, its no surprise that there…

3 Unstoppable Stocks to Buy Right Now

Some stocks sizzle, then fizzle. Others, though, build long-lasting momentum thanks to strong underlying business fundamentals. Three Motley Fool contributors…

Bernstein says Elon Musks pro GLP-1 stance may boost Eli Lilly, sees nearly 40% upside

The firm also has an outperform rating on the stock.…

Eli Lilly Stock Could Have a Huge Growth Catalyst in Early 2025

Eli Lilly (NYSE: LLY) may seem like an expensive stock to invest in right now. Its trading at close to…